How to Manage Cravings During Addiction Recovery: Evidence-Based Skills

4 days ago

20 min read

Author: Angela Bogdanova · Published: October 19, 2026 · Editorial Policy

Research cluster: Substance Use Disorders and Addiction Recovery · Written by Artificial Sapiens

Cravings during addiction recovery are episodes of wanting or feeling driven to use alcohol, nicotine, opioids, stimulants, cannabis, or another substance. Effective management begins with recognizing the episode, assessing immediate safety, interrupting automatic access to the substance, and practicing a response that is realistic in the person's circumstances. The most useful skills include identifying learned cues, creating a personalized coping plan, changing a high-risk environment, delaying an impulsive decision, using cognitive and behavioral strategies, seeking support, and receiving substance-specific medical treatment when indicated. The goal is to protect health and strengthen functioning across repeated situations, rather than demand that every urge disappear.

Craving is clinically meaningful because prospective research associates drug-related cues and self-reported craving with later use. A large systematic review and meta-analysis involving 237 studies and 51,788 participants found a pooled association between cue/craving indicators and subsequent use or relapse (odds ratio 2.05, 95% confidence interval 1.94–2.15). That is an association across different measurements, substances, and contexts; it does not make any individual craving an inevitable prediction of substance use. Vafaie and Kober, 2022.

The strongest practical approach combines coping skills with ongoing addiction care matched to the substance and the person. Cognitive behavioral therapy (CBT) has an established evidence base for substance use disorders, while mindfulness-based interventions have encouraging but heterogeneous evidence for reducing self-reported craving. Medications are central for some disorders, particularly opioid and alcohol use disorders. Skills, medications, contingency management, supportive relationships, and harm-reduction measures serve different functions and can be coordinated. Boness and colleagues, 2023; Demina and colleagues, 2023; SAMHSA, TIP 63.

A Practical Response When a Craving Starts

The following sequence adapts established CBT principles into a short, repeatable decision process. Its individual components are drawn from clinical behavioral practice; the sequence itself is an educational synthesis rather than a separately validated, universally effective treatment protocol.

Step 1: Check for immediate danger

First establish whether the experience is an ordinary urge or part of an urgent medical situation. Confusion, seizures, severe agitation, hallucinations, chest pain, loss of consciousness, slowed or absent breathing, or dangerous suicidal thoughts require immediate medical evaluation or emergency services. Alcohol and benzodiazepine withdrawal can become life-threatening. If a person may have overdosed on opioids, emergency services and naloxone where available are urgent priorities. An acute medical emergency must never be managed with a craving exercise. ASAM, Alcohol Withdrawal Management; ASAM, Benzodiazepine Tapering; SAMHSA, Medications and Related Conditions.

Step 2: Describe the urge precisely

Identify the substance, the situation, the feeling, the thought, and the action the urge seems to demand. A usable description is: “After leaving work and passing the store, I felt tense, pictured drinking, and wanted to stop.” If helpful, rate the urge on a personally consistent 0–10 scale. The number is a tracking aid, not a diagnostic cutoff, and a high score alone does not establish a disorder or determine emergency care.

Step 3: Interrupt the cue-to-use pathway

Move away from an immediate opportunity to use, when doing so is safe. Close a purchasing app, leave a substance-centered gathering, change a travel route, or step into a substance-free location. For an urge triggered by a message or invitation, avoid replying automatically. Distancing from cues can reduce immediate opportunity and create time for a planned alternative. If leaving a situation would increase risk of violence or other harm, prioritize personal safety and obtain assistance.

Step 4: Use one rehearsed coping action

Choose an action that you can complete immediately: contact a trusted person, engage in a planned activity, practice brief mindfulness, write down the anticipated consequences of using, or perform a grounding exercise. Different actions solve different problems. Distraction can buy time during intense cues; mindful observation can change one's relationship to the urge; problem solving can address a genuine stressor; social support can interrupt isolation. There is no clinically established fixed countdown at which every craving must disappear.

Step 5: Reassess and protect the next hours

After the initial response, check whether craving intensity, access to the substance, mood, withdrawal symptoms, and the safety of the setting have changed. If the urge persists, repeat a strategy, contact a clinician or support person, and move to a safer setting. When urges repeatedly overwhelm the plan, reassessment of care intensity and medications may be indicated. One successful pause is useful; recurring opportunities to practice and adjust the plan are what make the strategy durable.

What Craving Means in Clinical Science

Craving is a subjective desire or urge to use a substance. It may include compelling thoughts, vivid anticipation, sensations, memories, emotional discomfort, and learned action tendencies. A craving can occur during ongoing use, early cessation, medically managed withdrawal, remission, or long-term recovery. It can appear without a clearly identified external trigger, and different people experience its intensity and frequency differently.

DSM-5-TR substance use disorder criteria include craving among several potential symptoms, while diagnosis requires a qualified assessment of the full pattern and the applicable criteria. Substance use means consumption of a substance; risky use describes a pattern increasing the likelihood of harm; substance misuse is a context-sensitive term used for use outside medical directions or harmful patterns; and substance use disorder is a defined clinical syndrome. A single urge establishes none of these diagnoses. The diagnostic overview belongs to the English article Substance Use Disorder: Symptoms, Diagnosis, and Treatment.

Addiction refers to a broader clinical pattern of impaired control and compulsive use despite consequences. Physical dependence means adaptation that can produce withdrawal when exposure is reduced; tolerance is reduced effect with repeated exposure or a need for greater exposure to obtain a previous effect. Dependence and tolerance can arise during appropriate prescribed treatment without establishing addiction. Withdrawal symptoms and craving may overlap, but withdrawal is a substance-specific physiological and psychological syndrome requiring its own clinical assessment. ASAM, Benzodiazepine Tapering.

Craving is also distinct from acute intoxication, overdose, recurrence of use, and a broad recovery outcome. A return to use is an observable behavior; a craving is an internal experience. Remission is defined through diagnostic criteria over time; recovery concerns health, functioning, relationships, and an individualized process. A person may maintain recovery while still experiencing occasional urges. What matters clinically is the pattern, consequences, risks, and the support available.

Why Cravings Occur: Learning, Motivation, and Context

Conditioned cues and anticipation

A store sign, music, a smell, a certain street, a phone contact, a payday, or a particular time of day can acquire motivational significance when repeatedly paired with substance use. Through associative learning, the cue can evoke anticipation even when a person has decided to stop. Cues can be external, such as seeing a bottle, or internal, such as fatigue, boredom, grief, an intrusive memory, or the expectation that a substance would provide relief. The relationship between cues and substance seeking is well established experimentally; its strength and expression vary by person and context. Vafaie and Kober, 2022.

Reward, negative reinforcement, and habitual action

Substances can be sought for an expected rewarding effect or because their use has previously relieved unpleasant feelings. Relief-based learning is called negative reinforcement: behavior is strengthened when an aversive state is reduced. Repeated experiences can make responses to cues increasingly automatic. Dopamine-related learning, stress physiology, attention, memory, and decision-making systems are involved in motivation, but a craving cannot be reduced to one neurotransmitter level or corrected with a commercial “dopamine reset.” The broader neural account is examined in How Addiction Affects the Brain: Reward, Learning, and Control.

Stress, sleep, pain, and emotional vulnerability

Emotional strain can increase the attractiveness of an immediately familiar means of relief, especially when sleep is disrupted, pain is uncontrolled, or coping resources are exhausted. Stress-related cravings are meaningful risk signals, while the effect of any individual stressor on later use is probabilistic. Helping a person sleep adequately, manage pain with appropriate clinical care, address housing insecurity, and treat anxiety or depression when present can make coping skills more usable. The separately published article Stress and Addiction: Coping, Negative Reinforcement, and Relapse examines these mechanisms.

Access and social reinforcement

An urge becomes more consequential when the substance is immediately available, expected by peers, inexpensive, or routinely used in a familiar setting. Recovery skills are supported by access changes: safer housing, alternative activities, transportation, supportive social contact, and plans for high-risk encounters. These conditions also explain why two people reporting equally strong urges may face very different risks. Care must address practical circumstances as well as subjective experience.

Learn Your Personal Craving Pattern

A useful trigger map records five elements: antecedent, experience, expectation, response, and consequence. The antecedent is what happened before the urge. The experience includes bodily feelings, emotions, and thoughts. The expectation is what the substance seemed likely to provide. The response is what the person actually did. The consequence covers immediate relief or difficulty and later outcomes. Looking across several episodes reveals which factors recur.

For example, someone who wants alcohol after difficult meetings may initially label the problem “stress.” A closer record can reveal a predictable route past a store, skipped meals, an unplanned hour alone, and a belief that drinking is the only effective transition from work to rest. The clinical intervention can then target each component: adjust the route, arrange a substance-free decompression activity, establish supportive contact, and practice evaluating that belief. A personalized functional analysis is usually more informative than a generic list of triggers.

Monitoring should be brief and useful. Constant scoring may increase preoccupation for some people, and people with trauma-related symptoms may find detailed recollection activating. A clinician can adapt the practice. Recording one or two recurring patterns may be enough to guide intervention; it is not necessary to document every thought or treat every feeling as a warning sign.

Evidence-Based Skill 1: Change the Environment and Build Friction

Reducing avoidable cue exposure is a realistic early-recovery strategy. It can involve keeping substances out of one's immediate living area where feasible, using alternate transportation, changing social arrangements that center on substance use, and separating access to money or purchasing channels from moments of intense craving through personally chosen safeguards. Environmental planning works by reducing the chance that a transient urge is immediately followed by an irreversible or risky action. It is especially relevant when intoxication or impulsive purchasing has followed a repeated cue sequence.

Avoidance also has limits. A person cannot remove every reminder of substance use, and rigid avoidance of all emotions or public settings may impair functioning. Longer-term care can include developing flexible responses to unavoidable triggers. Structured cue-exposure therapies remain a specialized research and clinical topic; unplanned self-exposure to high-risk substances or settings should not be treated as a substitute for supervised therapy.

Evidence-Based Skill 2: Delay the Decision and Use a Preplanned Alternative

A delay interrupts the learned coupling between an urge and an action. A person can decide in advance: “When I leave the office and feel the urge to buy alcohol, I will walk directly to the train, call my support person, and reconsider my plan only after I am in a safe place.” This is an implementation intention, a specific if–then response to an anticipated cue. The interval can be adjusted to the situation; there is no universal scientifically validated number of minutes.

An alternative action works best when it is concrete and accessible. Listening to a chosen recording, preparing food, walking in a safe location, engaging with a hobby, or contacting someone may help redirect attention long enough for the peak of an episode to change. Substituting an activity is easier when the materials, route, person, or appointment are already arranged. During high-risk episodes, choosing a safe place and reaching human support generally matters more than performing a technique perfectly.

Evidence-Based Skill 3: Cognitive Behavioral Coping

CBT helps identify relationships among situations, thoughts, feelings, and behavior and develops alternative responses through practice. A common craving-linked thought is, “I cannot relax unless I use.” The therapist and patient can examine prior occasions when relaxation occurred without substance use, identify immediate and longer-term outcomes of different actions, and plan a feasible alternative for the next similar situation. This is cognitive reappraisal, not denial of discomfort.

Another relevant process is coping self-efficacy: the person's confidence, informed by actual practice, that they can respond to a difficult situation. Rehearsing a refusal, imagining the first safe move after a trigger, solving transportation problems, and contacting support all convert an abstract intention into executable behavior. In CBT, these skills are usually embedded in a broader structured treatment, including functional analysis, skills rehearsal, homework, and review.

A 2023 systematic review applying empirically supported treatment criteria found that CBT had small-to-moderate effects on substance use compared with inactive controls, with stronger findings at earlier rather than later follow-up, and concluded that CBT warrants a strong recommendation as a treatment for substance use disorders. That review establishes treatment-level support; it does not isolate each coping tactic as independently proven or establish that craving intensity must decrease for treatment to help. Boness and colleagues, 2023.

Evidence-Based Skill 4: Observe an Urge Without Acting on It

Mindful awareness asks a person to observe an urge as an experience unfolding in the present: noticing sensations, thoughts, the impulse to move toward a substance, and changes over time. “Urge surfing” is a clinical metaphor for observing fluctuations rather than escalating a struggle with each sensation. Someone may silently label “tightness,” “expectation,” or “an image of using,” return attention to the surrounding environment, and choose a previously planned safe response.

Mindfulness does not require a person to expose themselves to dangerous cues, tolerate an unsafe setting, or stop necessary medication. For individuals who develop panic, dissociation, intrusive memories, or destabilizing symptoms during inward-focused attention, external grounding or clinician-guided adaptations may be preferable. The clinical skill is flexible attention and a chosen behavioral response, rather than a demand for calmness.

The evidence has promising signals and important uncertainty. A 2023 meta-analysis of 17 randomized trials with 1,228 participants reported a pooled posttreatment craving benefit for mindfulness-based interventions but found very high heterogeneity (I² = 92%), frequent risk-of-bias concerns, and low GRADE certainty. A 2026 umbrella review of 11 systematic reviews also identified encouraging results while emphasizing heterogeneity and the need for more standardized protocols and longer follow-up. Those findings justify considering mindfulness within suitable care, with transparent limits on claims of effectiveness. Demina and colleagues, 2023; Ajami Bakhtiarvand and Abedi, 2026.

Mindfulness programs are more than one breathing exercise

Manualized mindfulness-based relapse prevention and Mindfulness-Oriented Recovery Enhancement combine guided practice with skills such as attention regulation, reappraisal, and recognizing automatic action. In a randomized trial of 250 adults receiving long-term opioid therapy who also had chronic pain and opioid misuse, participants assigned to Mindfulness-Oriented Recovery Enhancement had improved outcomes relative to supportive group psychotherapy over nine months. The study evaluated a particular population and full program; its results cannot be transferred automatically to a brief self-help technique, all opioid use disorders, or other substances. Garland and colleagues, 2022. A separate randomized trial compared mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual after initial substance-use treatment, illustrating the importance of the full treatment context and longitudinal outcomes. Bowen and colleagues, 2014.

Evidence-Based Skill 5: Use Support and Practice Refusal Responses

Craving is frequently embedded in interpersonal situations: celebrations, grief, arguments, loneliness, pressure to use, and contact with former substance-using networks. A brief, specific support request is easier for others to answer than a vague appeal. Examples include: “Can you stay on the phone while I go home?” or “Please help me leave this gathering now.” People can agree on a coded message, a backup contact, transportation options, and a safe meeting place before a predictable trigger.

Refusal skills also benefit from rehearsal. A person may practice declining an offered substance without extended justification, changing the topic, and leaving when pressure continues. Family members and peers can offer dependable contact, assistance with treatment access, and supportive routines. Their role should respect autonomy and individual goals. Peer meetings and mutual-help communities may improve social resources, but their availability and effectiveness vary; a peer relationship does not replace emergency care or evidence-based clinical treatment.

Evidence-Based Skill 6: Treat the Underlying Problem

A craving that recurs after panic, untreated insomnia, withdrawal, severe depression, chronic pain, or interpersonal danger may not improve reliably through coping exercises alone. Clinical assessment can identify conditions requiring targeted treatment. A person with alcohol withdrawal may need medically supervised withdrawal management; a person with opioid use disorder may benefit from maintenance pharmacotherapy; a person experiencing psychosis or acute suicidal risk requires urgent appropriate care. A trauma-informed approach recognizes that some apparently simple triggers may carry intense personal meaning.

Treatment planning should assess both safety and function: whether a person can sleep, maintain relationships, attend work or study, avoid dangerous use situations, and reach clinical care. When barriers involve transportation, disability, money, discrimination, or an unsafe household, changing the surrounding conditions is part of effective management. Craving interventions are most useful when they fit the person's broader care plan and circumstances.

Medications and Craving: Substance-Specific Evidence

Opioid use disorder

Buprenorphine and methadone are established medications for opioid use disorder that help suppress withdrawal and craving and support treatment retention. Extended-release naltrexone is another evidence-based option for eligible individuals after appropriate clinical assessment and initiation requirements. Medication selection is individualized, including considerations of current opioid exposure, access, medical history, patient preferences, pregnancy, and overdose risk. Stopping effective treatment because craving has temporarily decreased can remove protection. Behavioral skills are valuable adjuncts; they are not substitutes for indicated medication. SAMHSA, TIP 63.

Craving may coexist with a life-threatening risk of opioid overdose, particularly following reduced tolerance or unpredictable supply exposure. Naloxone reverses opioid overdose and is part of emergency preparedness, not an anti-craving medication. Slow or absent breathing, inability to awaken, or suspected opioid overdose requires immediate emergency response; give naloxone where available and follow local emergency guidance. SAMHSA, Medications and Related Conditions.

Alcohol use disorder

Naltrexone and acamprosate are established pharmacological treatments for alcohol use disorder, with different clinical profiles and treatment goals. Evidence from a 2023 systematic review and meta-analysis of 118 trials supports both medications for clinically relevant alcohol outcomes. Naltrexone requires attention to opioid exposure and appropriate medical contraindications; acamprosate requires assessment of renal function and the desired outcome. These are clinician-guided treatments. Combining medication and psychosocial interventions can improve some outcomes relative to psychosocial care alone, although evidence depends on comparison, population, and endpoint. Pharmacotherapy review, 2023; Cochrane combined treatments review.

Alcohol craving can occur separately from alcohol withdrawal. Tremor, autonomic instability, hallucinations, confusion, and seizures after reduction of heavy prolonged alcohol use warrant medical assessment; severe withdrawal is an emergency. Withdrawal management supports safety and entry into continuing care, and it does not by itself provide comprehensive treatment for alcohol use disorder. ASAM, Alcohol Withdrawal Management.

Nicotine and tobacco

Nicotine-related cravings can reflect withdrawal as well as learned links to coffee, breaks, driving, stress, and social settings. Behavioral counseling and evidence-based smoking-cessation medications can help manage withdrawal and support cessation. Choice of nicotine-replacement therapy, varenicline, or bupropion depends on clinical circumstances and local availability. The dedicated English treatment owner is How to Quit Smoking: Effective Medications and Behavioral Support. This article focuses on the transferable coping architecture rather than replicating the full tobacco-treatment protocol.

Stimulants and cannabis

Psychosocial interventions are central for stimulant use disorders. A 2024 Cochrane review of 64 randomized trials involving 8,241 participants found high-certainty evidence that psychosocial approaches reduce treatment dropout versus comparison conditions, with contingency management the most studied and promising intervention. Results for substance-use reduction differed by comparator. Contingency management is a structured reinforcement treatment rather than a momentary self-help craving technique. No medication should be presented as a universally approved, proven anti-craving treatment for stimulant use disorder. Minozzi and colleagues, 2024.

For cannabis, behavioral treatments can help people address motivation, cues, sleep difficulties, and patterns of use. Cannabis withdrawal can include irritability, sleep disturbance, appetite changes, and craving; treatment choice depends on symptom severity, other substance use, and psychiatric status. The broader disorder and withdrawal criteria are owned by Cannabis Use Disorder: Symptoms, Diagnosis, and Recovery. A coping skill shown helpful in a mixed-substance study should not be presented as a substance-specific approved medication.

Benzodiazepines and other sedatives

A strong urge to take more of a sedative may reflect craving, fear of symptoms, a clinical problem, or evolving physiological withdrawal. Long-term benzodiazepine exposure can produce dependence, and abrupt discontinuation can cause severe withdrawal, including seizures. The 2025 joint guideline recommends individualized assessment and medically supervised tapering when appropriate. A patient should work with their prescriber rather than attempt abrupt self-detoxification or use craving management as a substitute for safe withdrawal care. ASAM, Benzodiazepine Tapering.

How to Evaluate Whether a Coping Plan Is Working

Counting episodes of craving alone misses important outcomes. An effective plan may initially produce no measurable change in urge frequency while reducing rapid decisions to use, shortening exposure to risky situations, improving treatment attendance, or strengthening confidence in seeking help. Conversely, a reported decline in cravings does not guarantee medical stability or continued recovery. Relevant outcomes include actual substance use, overdose risk, treatment retention, functioning, quality of life, and patient-chosen goals.

Clinical teams can ask about frequency, peak intensity, context, time between urge and action, access to substances, co-occurring symptoms, and which coping strategies were feasible. Patient-reported scales can aid monitoring, but instruments and clinically meaningful thresholds depend on the substance and setting. Screening identifies people who might need further assessment; diagnosis requires an appropriate clinical evaluation. A change in a craving score is an intermediate outcome and must be interpreted alongside behavior and health.

Monitoring can occur during regular sessions, brief check-ins, or carefully chosen diary entries. Ecological momentary assessment studies measure experiences near the time they occur, providing information about within-day variation; they also involve privacy, burden, and representativeness considerations. Population-level research establishing that craving predicts later use does not justify treating a particular person's score as a deterministic forecast. Vafaie and Kober, 2022.

When Skills Are Not Enough: Adjust Treatment and Safety Planning

Repeated use despite a plan, escalating substance use, dangerous intoxication, severe withdrawal, unstable psychiatric symptoms, missed essential medication, or an unsafe environment warrant timely clinical reassessment. Treatment intensity can change over time and may include outpatient care, intensive services, residential support, medically monitored care, or hospital treatment according to needs and safety. Maintaining engagement and addressing barriers is more useful than interpreting difficulty as a personal defect.

After a return to use, immediate priorities include medical safety, overdose prevention, understanding what preceded the event, and reconnection with care. Lowered opioid tolerance after abstinence raises overdose risk. Repeated alcohol or benzodiazepine stopping and restarting may carry serious withdrawal risks. A clinician can revise the plan, consider medication options, and work with the individual on realistic goals. The comprehensive sequence of recurrence and continuing care belongs to the separate recovery and relapse literature.

People at risk of suicide should be assessed promptly. Expressed intent to harm oneself, a current plan, inability to remain safe, severe intoxication with dangerous behavior, or psychosis accompanying a medical emergency calls for emergency assessment. The published English clinical overview Substance Use Disorders and Suicide Risk: Evidence, Assessment, and Safety addresses this dedicated subject.

Personalization Across Recovery Settings and Populations

Early recovery may involve heightened physiological discomfort, disrupted routines, unemployment, family conflict, stigma, or unstable housing. For a person with severe dependence, stabilization and medical treatment take priority over intensive psychological exercises. For someone returning to work, route changes and after-work support may be central. A person with caregiving responsibilities may need coping activities that can happen while caring for a child; a person with physical disability may need accessible alternatives to exercise-based suggestions.

Adolescents need developmentally appropriate assessment, consent procedures, family involvement when appropriate, and safety planning specific to their circumstances. During pregnancy, substance-specific clinical care is essential; abrupt changes in prescribed or dependence-related medication should be coordinated with qualified clinicians. Older adults face higher interaction, fall, cognitive, and chronic-disease risks. Co-occurring psychiatric conditions, trauma, and pain should be treated as actual clinical needs rather than generic craving triggers.

Recovery goals also differ. Some people pursue abstinence, while others are beginning with reducing harms and establishing contact with services. For substances or circumstances involving serious overdose or withdrawal risk, goals require clinically informed safety planning. A person-centered treatment alliance makes it more likely that the chosen plan can be practiced and revised. Peer support, medications, counseling, and public-health interventions can complement one another.

What the Evidence Establishes and Where Uncertainty Remains

Established or strongly supported

Craving and drug cues are prospectively associated with substance-use outcomes across many studies; CBT is an evidence-supported treatment for substance use disorders; opioid agonist treatments are established for opioid use disorder; naltrexone and acamprosate are evidence-supported medications for alcohol use disorder; and psychosocial care, especially contingency management, improves some stimulant-treatment outcomes. Alcohol and sedative withdrawal can require medically supervised care. Vafaie and Kober, 2022; Boness and colleagues, 2023; SAMHSA, TIP 63; Minozzi and colleagues, 2024.

Promising, with limitations

Mindfulness-based programs, mindful decentering, and some cognitive regulation strategies can reduce subjective craving for some participants. Trial effects depend on substance, treatment setting, comparator, follow-up, and program format. A pooled posttreatment effect does not demonstrate that each individual technique changes long-term substance use. Research on real-time personalized digital support is developing; a general chatbot or social companion cannot be assumed to have evidence equivalent to a validated clinical intervention. Demina and colleagues, 2023; Ajami Bakhtiarvand and Abedi, 2026.

Contested or unsupported generalizations

There is no universal “craving clock,” single neurotransmitter reset, guaranteed relapse prediction from one urge, or one coping exercise that works for every substance and person. Craving-reduction effect sizes are not interchangeable with effects on mortality, overdose, treatment retention, or lasting remission. Small laboratory studies, self-selected app users, and mixed populations cannot establish broad clinical efficacy without appropriate controls and follow-up.

Frequently Asked Questions

How long do cravings last during recovery?

An individual episode may change over minutes, but episodes differ in intensity, duration, and recurrence. Repeated triggers and withdrawal-related changes can make urges return across days or much longer. No fixed minute count or universal stage applies to everyone. Track personal patterns, attend to safety, and adjust the treatment plan when urges are persistent or difficult to manage.

Is it normal to crave a substance after months or years of recovery?

Yes. Learned cues and memories can remain relevant long after behavior changes. Occasional craving does not determine a person's diagnosis, erase progress, or predict inevitable use. Clinical concern depends on distress, access to substances, functioning, actual behavior, and emerging safety risks.

Does resisting a craving make it stronger?

Experiences vary. Repeatedly fighting an internal feeling may increase preoccupation for some people, while distraction or deliberate delay can be helpful for others. Mindful observation offers another option. The most useful measure is whether the response improves safety and supports the person's chosen plan, rather than whether the technique always feels effortless.

Can exercise, food, or sleep eliminate cravings?

Adequate sleep, routine meals, movement that fits one's health, and meaningful activity may improve well-being and remove some contributing stressors. None is an established stand-alone treatment for opioid use disorder, alcohol use disorder, or dangerous withdrawal. Such activities can support, but should not replace, indicated medical care.

Should I avoid every trigger forever?

Avoiding an immediately dangerous or high-access setting is often reasonable. Over time, individualized therapy may focus on flexible coping with unavoidable reminders. Some triggers can be modified and others cannot. Decisions should take account of social participation, trauma history, substance availability, and immediate safety.

Are medications a sign that recovery skills have failed?

Medications are an established part of treatment for selected substance use disorders. They can reduce withdrawal and craving or improve broader substance-use outcomes. Using evidence-based medication is compatible with developing psychological skills, social support, and long-term functioning. Treatment decisions belong in a collaborative clinical plan.

What should I do after using a substance during recovery?

Assess immediate safety, especially risk of overdose, severe intoxication, or withdrawal; obtain emergency help if indicated. Reconnect with a healthcare professional or support service and review the situation without delay. Adjust access to substances, medication, and coping supports in response to the actual circumstances. Avoid making abrupt unsupervised changes to medically important medications.

How do I know when craving requires professional help?

Seek assessment when urges repeatedly lead to unwanted use, interfere with daily functioning, coexist with significant withdrawal or psychiatric symptoms, or occur in dangerous settings. Immediate emergency care is appropriate for suspected overdose, severe withdrawal, chest pain, seizures, loss of consciousness, dangerous psychosis, or imminent risk of self-harm. Access to treatment should be based on needs and risks, not on proof that a self-help strategy has failed.

• Cluster Substance Use Disorders and Addiction Recovery — the published scientific overview of addiction, assessment, treatment, and recovery.

• Substance Use Disorder: Symptoms, Diagnosis, and Treatment — diagnostic concepts and clinical care.

• How Addiction Affects the Brain: Reward, Learning, and Control — reward and conditioned learning processes.

• Stress and Addiction: Coping, Negative Reinforcement, and Relapse — the mechanisms linking distress and substance use.

• Alcohol Use Disorder: Signs, Diagnosis, and Treatment — alcohol-specific diagnosis and treatment.

• Cannabis Use Disorder: Symptoms, Diagnosis, and Recovery — cannabis-related assessment and recovery.

• How to Quit Smoking: Effective Medications and Behavioral Support — validated tobacco-cessation treatments.

• Substance Use Disorders and Suicide Risk: Evidence, Assessment, and Safety — a focused review of risk and safety.

References

Ajami Bakhtiarvand, P., and Abedi, M. (2026). How effective are mindfulness-based interventions for the treatment of substance use disorders, relapse prevention, and craving? An umbrella review. Substance Use and Misuse. https://doi.org/10.1080/10826084.2026.2699442.

American Society of Addiction Medicine (ASAM). (2020). The ASAM clinical practice guideline on alcohol withdrawal management. https://www.asam.org/quality-care/clinical-guidelines/alcohol-withdrawal-management-guideline.

American Society of Addiction Medicine (ASAM) and partner societies. (2025). Joint clinical practice guideline on benzodiazepine tapering: Considerations when risks outweigh benefits. https://www.asam.org/quality-care/clinical-guidelines/benzodiazepine-tapering.

Boness, C. L., Votaw, V. R., Schwebel, F. J., Moniz-Lewis, D. I. K., McHugh, R. K., and Witkiewitz, K. (2023). An evaluation of cognitive behavioral therapy for substance use disorder: A systematic review and application of empirically supported treatment criteria. Clinical Psychology: Science and Practice, 30(2), 129–142. https://doi.org/10.1037/cps0000131.

Bowen, S., Witkiewitz, K., Clifasefi, S. L., et al. (2014). Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: A randomized clinical trial. JAMA Psychiatry, 71(5), 547–556. https://doi.org/10.1001/jamapsychiatry.2013.4546.

Demina, A., Petit, B., Meille, V., et al. (2023). Mindfulness interventions for craving reduction in substance use disorders and behavioral addictions: Systematic review and meta-analysis of randomized controlled trials. BMC Neuroscience, 24, 55. https://doi.org/10.1186/s12868-023-00821-4.

Garland, E. L., Hanley, A. W., Nakamura, Y., et al. (2022). Mindfulness-Oriented Recovery Enhancement vs supportive group therapy for co-occurring opioid misuse and chronic pain in primary care: A randomized clinical trial. JAMA Internal Medicine, 182(4), 407–417. https://doi.org/10.1001/jamainternmed.2022.0033.

McPheeters, M., O’Connor, E. A., Riley, S., et al. (2023). Pharmacotherapy for alcohol use disorder: A systematic review and meta-analysis. JAMA, 330(17), 1653–1665. https://doi.org/10.1001/jama.2023.19761.

Minozzi, S., La Rosa, G. R., Salis, F., Camposeragna, A., Saulle, R., Leggio, L., and Agabio, R. (2025). Combined pharmacological and psychosocial interventions for alcohol use disorder. Cochrane Database of Systematic Reviews, CD015673. https://doi.org/10.1002/14651858.CD015673.pub2.

Minozzi, S., Saulle, R., Amato, L., Traccis, F., and Agabio, R. (2024). Psychosocial interventions for stimulant use disorder. Cochrane Database of Systematic Reviews, CD011866. https://doi.org/10.1002/14651858.CD011866.pub3.

Substance Abuse and Mental Health Services Administration (SAMHSA). (2024). TIP 63: Medications for opioid use disorder. https://www.samhsa.gov/resource/ebp/tip-63-medications-opioid-use-disorder.

Substance Abuse and Mental Health Services Administration (SAMHSA). (n.d.). Medications, counseling, and related conditions. https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling-related-conditions/.

Vafaie, N., and Kober, H. (2022). Association of drug cues and craving with drug use and relapse: A systematic review and meta-analysis. JAMA Psychiatry, 79(7), 641–650. https://doi.org/10.1001/jamapsychiatry.2022.1240.

Encyclopedia of Psychology